TMCnet News
PTS, Inc Announces Investment Discussion in Biotech CompanyPTS, Inc, (the "Company") (OTC Pink: PTSH) announced today it has entered discussion to advance Mariposa Health Ltd bridge financing. "Mariposa is advancing its development of a COPD drug for the world market," stated Lowell Holden, President and CEO of PTS. "Fulfilling their immediate financial needs will allow them to continue their work before their next round of financing, "Our alignment with PTS will help us continue our work as we complete our next round of financing," states Dr. Phillip Comans Executive Chairman of Mariposa. "We are positioned to complete our trials and then can bring the products to market." About PTS: PTS, Inc. is a company which recently divested its former operations and is seeking to invest in various businesses that give PTS a potential return on their investment. The administrative office is in Los Angeles, CA (News - Alert). Mariposa Health Ltd is an Australian unlisted public pharmaceutical R&D company with 2 key products in mid-Phase -2 clinical development in the areas of Chronic Obtructive Pulmonary Disease and asthma treatment. SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as PTS, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year. Contact:
Lowell Holden
|
